目的：观察细菌脂多糖（LPS）对支气管哮喘小鼠血清IL-4、IL-8及肺组织血管内皮生长因子（VEGF）的影响，探讨LPS在哮喘发生过程中的调节作用。方法：27只BALB/c小鼠随机分为对照组、哮喘组和LPS干预组，每组9只。采用ELISA法检测哮喘小鼠血清IL-4、IL-8的浓度，免疫组织化学染色法检测肺组织中VEGF的表达。结果：哮喘组血清IL-4和IL-8水平明显高于对照组（P<0.05）；而LPS干预组IL-4和IL-8水平明显低于哮喘组（P<0.05），但仍高于对照组（P<0.05）。哮喘组气道VEGF表达显著高于对照组（P<0.05）；LPS干预组其表达明显低于哮喘组（P<0.05），但仍高于对照组（P<0.05）。结论：LPS可能通过降低哮喘小鼠血清IL-4和IL-8水平及气道VEGF表达，减轻气道炎症，减少气道血管重塑的发生。
Abstract
OBJECTIVE: To study the regulatory role of bacterial lipopolysaccharide (LPS ) in the development of bronchial asthma by examining the effects of LPS on serum IL-4, serum IL-8 and pulmonary vascular endothelial growth factor (VEGF) expression in mice with asthma. METHODS: Twenty-seven BALB/c mice were randomly assigned into control, asthma and LPS-treated asthma groups (n=9 each). Serum IL-4 and IL-8 concentrations were measured using ELISA. VEGF expression in lung tissues was examined using the immunohistochemical method. RESULTS: Serum IL-4 and IL-8 concentrations in the asthma group were significantly higher than in the control group (P<0.05). LPS treatment significantly decreased serum IL-4 and IL-8 concentrations compared with the asthma group (P<0.05), although levels were significantly higher than in the control group (P<0.05). Airway VEGF expression in the asthma group was significantly higher than in the control group (P<0.05). LPS treatment significantly decreased airway VEGF expression compared with the asthma group (P<0.05), although concentrations remained higher than in the control group (P<0.05). CONCLUSIONS: LPS can decrease serum IL-4, serum IL-8 and pulmonary VEGF expression in mice with asthma, and thus can possibly reduce both airway inflammation and airway vascular remodeling.
关键词
哮喘 /
脂多糖 /
IL-4 /
IL-8 /
血管内皮生长因子 /
气道重塑 /
小鼠
Key words
Asthma /
Lipopolysaccharide /
IL-4 /
IL-8 /
Vascular endothelial growth factor /
Airway vascular remodeling /
Mice
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
［1］Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children［J］. N Engl J Med, 2002, 347(12): 869-877.
［2］胡东，张荣波. 脂多糖对过敏性哮喘患者细胞因子分泌的影响［J］.现代预防医学，2007,34（2）:237-239.
［3］金小红，李昌崇，陈存国，李绍波，李凤仙，干灵红. 支气管哮喘大鼠血管内皮生长因子与γ-干扰素、白细胞介素-4变化的相关性及布地奈德干预对其的影响［J］. 实用儿科临床杂志，2009,24（4）：282-284.
［4］沈观炘，杨烁，郭少川. 白三烯受体拮抗剂治疗儿童哮喘的疗效观察［J］.中国医药指南，2009，7（15）：31-33.
［5］栾斌，黄先杰，乔俊英. SDF21及CXCR4在哮喘小鼠肺组织中的表达及布地奈德的干预作用［J］．中国当代儿科杂志，2010，12（3）：215-218.
［6］Steinke JW, Borish. TH2 cytokine and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists［J］. Respir Res, 2001, 2(20): 66-70.
［7］Randolph DA, Stephens R, Carruthers CJ, Chaplin DD. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation［J］. J Clin Invest, 1999, 104(8):1021-1029.
［8］Ryan JJ, McReynolds LJ, Keegan A, Wang LH, Garfein E, Rothman P, et al. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor［J］. Immunity, 1996, 4(2):123-132.
［9］Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation［J］. J Allergy Clin Immunol, 1995, 95（4）: 843-852.
［10］Takeda K, Kaisho T, Akira S. Toll-like receptors［J］. Annu Rev Immunol, 2003, 21: 335-376.
［11］冯琳琳，代继宏，符州，刘铮，王莉佳，李欣. 脂多糖、转化因子-β1对小鼠骨髓来源树突状细胞的生物学作用［J］.细胞与分子免疫学杂志,2009,25(10):891-893.
［12］李鸿佳，王淑娟，李艳丽，董亮. 不同剂量脂多糖预处理对哮喘小鼠肺部炎症的影响的研究［J］.细胞与分子免疫学杂志，2008，24（10）：1008-1010.
［13］Walters EH, Reid D, Soltani A, Ward C. Angiogenesis: apotentially critical part of remodelling in chronic airway diseases?［J］. Pharmacol Ther, 2008, 118(1): 128-137.
［14］Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors［J］. Nat Med, 2003, 9(6): 669-676.
［15］Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung［J］. Am J Physiol Lung Cell Mol Physiol, 2006, 290(2): L209-L221.
［16］戴建，殷凯生，孙培莉. 咪喹莫特对哮喘小鼠气道反应性及气道重塑的影响［J］．南京医科大学学报（自然科学版），2009，29（1）：50-54.
PDF(1092 KB)
